Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

about

Natural history of t(11;14) multiple myeloma.Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.Multiple myeloma

P2860

Q48214992-700A9A7A-3286-4155-AA49-342373BAC806 Q55310350-EC0C1CE0-92BF-4632-925C-31D1B601C450 Q56657250-49CA9E89-C925-4078-B39E-6C5D921ACE93

P2860

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

Item

http://www.wikidata.org/entity/Q39788992

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Translocation t

@nl

Translocation t(11;14) in newl ...... eloma: Is it always favorable?

@en

type

Item

label

Translocation t

@nl

Translocation t(11;14) in newl ...... eloma: Is it always favorable?

@en

prefLabel

Translocation t

@nl

Translocation t(11;14) in newl ...... eloma: Is it always favorable?

@en

P1476

Translocation t(11;14) in newl ...... eloma: Is it always favorable?

@en

P2093

Abraham Avigdor

http://www.w3.org/2001/XMLSchema#string

Adrian Duek

http://www.w3.org/2001/XMLSchema#string

Arnon Nagler

http://www.w3.org/2001/XMLSchema#string

Chezi Ganzel

http://www.w3.org/2001/XMLSchema#string

Gabriela Rozic

http://www.w3.org/2001/XMLSchema#string

Galina Ishoev

http://www.w3.org/2001/XMLSchema#string

Ilya Novikov

http://www.w3.org/2001/XMLSchema#string

Itay Zilbershats

http://www.w3.org/2001/XMLSchema#string

Izhar Hardan

http://www.w3.org/2001/XMLSchema#string

Luba Trakhtenbrot

http://www.w3.org/2001/XMLSchema#string

P2860

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma

The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance

Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations

The multiparametric scanning system for evaluation of minimal residual disease in hematological malignancies.

CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

P304

710-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.22372

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27152944

http://www.w3.org/2001/XMLSchema#string

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

about

P2860

P2860

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698